Skip to main content
Equibles
CING logo

CING · Cingulate Inc. · Metrics

Track CING — free

Use CING with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CING.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.75 -0.01 (-0.21%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These uncertainties raise substantial doubt about our ability to continue as a going concern for one year after the issuance date of our financial statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$70.46M
Shares
14.54M
Volume · Oct 5 139.95K Avg daily vol (3M) 157.46K

CING metrics

49 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.76
Market cap
$70.46M

Price action

20 metrics
Price change (1W)
-1.4%
Price change (30D)
-8.3%
Price change (3M)
-11.5%
Price change (6M)
-22.5%
Price change (YTD)
+9.7%
Price change (1Y)
+17.2%
Trailing year
Price change (5Y)
—
52-week high
$11.66
52-week low
$3.33
Change from 52-week high
-59.2%
Change from 52-week low
+42.9%
Annualized volatility
87.6%
Annualized volatility (3M)
42.4%
Beta
1.3
RSI (14D)
38.8
Price vs SMA 50
-6.4%
Price vs SMA 200
-11.8%
Avg volume (3M)
157,459
Relative volume
0.3
Average dollar volume
$786,142

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
14.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.0
reciprocal yield 33.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-40.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-05-29

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$24.92M
Net income (TTM)
−$28.80M
Trailing 12 months
Diluted EPS (TTM)
$-3.64
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.35

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+200.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-122.7%
Return on assets
-87.1%
Debt / equity
—
Current ratio
3.5
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$28.40M
Total assets
$33.07M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$20.65M
Capital expenditures (TTM)
$284,476
R&D (TTM)
$8.52M
SG&A (TTM)
—
Stock compensation (TTM)
$1.93M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
40
13F filer change QoQ
+10
Institutional ownership
16.9%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 13.5 days to cover
Days to cover
13.5d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1862150 CUSIP 17248W303 13F (30d) 1 filings 1 filers Visit website Investor relations